Profile | GDS5420 / 243656_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 340.53 | 61 |
GSM1296119 | B_lesional_pre-dose | 293.83 | 59 |
GSM1296076 | C_lesional_pre-dose | 254.04 | 58 |
GSM1296092 | D_lesional_pre-dose | 178.49 | 52 |
GSM1296103 | E_lesional_pre-dose | 261.89 | 57 |
GSM1296078 | F_lesional_pre-dose | 145.67 | 49 |
GSM1296107 | G_lesional_pre-dose | 245.44 | 55 |
GSM1296109 | H_lesional_pre-dose | 249.34 | 55 |
GSM1296080 | I_lesional_pre-dose | 309.72 | 60 |
GSM1296090 | J_lesional_pre-dose | 255.84 | 57 |
GSM1296074 | K_lesional_pre-dose | 284.2 | 60 |
GSM1296111 | L_lesional_pre-dose | 231.13 | 54 |
GSM1296099 | M_lesional_pre-dose | 271.66 | 57 |
GSM1296086 | O_lesional_pre-dose | 248 | 57 |
GSM1296117 | P_lesional_pre-dose | 291.59 | 58 |
GSM1296113 | Q_lesional_pre-dose | 306.64 | 58 |
GSM1296096 | R_lesional_pre-dose | 209.67 | 53 |
GSM1296105 | S_lesional_pre-dose | 293.26 | 58 |
GSM1296098 | T_lesional_pre-dose | 639.97 | 72 |
GSM1296101 | U_lesional_pre-dose | 520.54 | 68 |
GSM1296121 | V_lesional_pre-dose | 257.18 | 56 |
GSM1296088 | W_lesional_pre-dose | 211.93 | 54 |
GSM1296082 | X_lesional_pre-dose | 115.36 | 45 |
GSM1296115 | Y_lesional_pre-dose | 239.11 | 55 |
GSM1296084 | Z_lesional_pre-dose | 369.17 | 63 |
GSM1296072 | B_lesional_day8 | 409.63 | 64 |
GSM1296069 | L_lesional_day8 | 380.17 | 62 |
GSM1296071 | P_lesional_day8 | 416.54 | 64 |
GSM1296070 | Y_lesional_day8 | 305.73 | 58 |
GSM1296073 | V_lesional_day8 | 258.62 | 57 |
GSM1296034 | A_lesional_day15 | 917.25 | 78 |
GSM1296041 | G_lesional_day15 | 321.03 | 60 |
GSM1296035 | R_lesional_day15 | 313.66 | 60 |
GSM1296038 | U_lesional_day15 | 233.4 | 55 |
GSM1296047 | B_lesional_day15 | 448.2 | 66 |
GSM1296039 | E_lesional_day15 | 302.16 | 60 |
GSM1296042 | H_lesional_day15 | 250.14 | 55 |
GSM1296043 | L_lesional_day15 | 313.85 | 59 |
GSM1296037 | M_lesional_day15 | 570.44 | 70 |
GSM1296046 | P_lesional_day15 | 538.06 | 68 |
GSM1296044 | Q_lesional_day15 | 430.39 | 64 |
GSM1296045 | Y_lesional_day15 | 400.84 | 63 |
GSM1296025 | C_lesional_day15 | 679.51 | 73 |
GSM1296033 | D_lesional_day15 | 350.96 | 62 |
GSM1296027 | I_lesional_day15 | 320.89 | 61 |
GSM1296032 | J_lesional_day15 | 550.98 | 69 |
GSM1296024 | K_lesional_day15 | 716.81 | 74 |
GSM1296031 | W_lesional_day15 | 404.41 | 63 |
GSM1296028 | X_lesional_day15 | 258.05 | 57 |
GSM1296029 | Z_lesional_day15 | 396.3 | 64 |
GSM1296026 | F_lesional_day15 | 279.32 | 59 |
GSM1296030 | O_lesional_day15 | 276.03 | 59 |
GSM1296040 | S_lesional_day15 | 277.25 | 57 |
GSM1296036 | T_lesional_day15 | 581.66 | 70 |
GSM1296048 | V_lesional_day15 | 360.03 | 62 |
GSM1296059 | A_lesional_day43 | 255.77 | 57 |
GSM1296066 | G_lesional_day43 | 331.21 | 60 |
GSM1296060 | R_lesional_day43 | 294.19 | 58 |
GSM1296063 | U_lesional_day43 | 192.74 | 52 |
GSM1296064 | E_lesional_day43 | 219.56 | 55 |
GSM1296067 | H_lesional_day43 | 460.06 | 65 |
GSM1296062 | M_lesional_day43 | 373.98 | 62 |
GSM1296068 | Q_lesional_day43 | 475.98 | 66 |
GSM1296050 | C_lesional_day43 | 346.09 | 62 |
GSM1296057 | D_lesional_day43 | 608.44 | 71 |
GSM1296052 | I_lesional_day43 | 329.7 | 61 |
GSM1296054 | J_lesional_day43 | 734.75 | 74 |
GSM1296049 | K_lesional_day43 | 588.68 | 70 |
GSM1296055 | W_lesional_day43 | 468.82 | 66 |
GSM1296053 | X_lesional_day43 | 451.47 | 66 |
GSM1296058 | Z_lesional_day43 | 486.48 | 67 |
GSM1296051 | F_lesional_day43 | 259.94 | 58 |
GSM1296056 | O_lesional_day43 | 310.77 | 60 |
GSM1296065 | S_lesional_day43 | 256.56 | 56 |
GSM1296061 | T_lesional_day43 | 581.13 | 69 |
GSM1296095 | A_non-lesional_pre-dose | 301.87 | 60 |
GSM1296120 | B_non-lesional_pre-dose | 404.11 | 64 |
GSM1296077 | C_non-lesional_pre-dose | 514.97 | 68 |
GSM1296093 | D_non-lesional_pre-dose | 635.38 | 71 |
GSM1296104 | E_non-lesional_pre-dose | 409.42 | 64 |
GSM1296079 | F_non-lesional_pre-dose | 365.85 | 63 |
GSM1296108 | G_non-lesional_pre-dose | 352.65 | 61 |
GSM1296110 | H_non-lesional_pre-dose | 338.22 | 60 |
GSM1296081 | I_non-lesional_pre-dose | 561.31 | 70 |
GSM1296091 | J_non-lesional_pre-dose | 339.11 | 61 |
GSM1296075 | K_non-lesional_pre-dose | 357.42 | 63 |
GSM1296112 | L_non-lesional_pre-dose | 362.66 | 61 |
GSM1296100 | M_non-lesional_pre-dose | 535.82 | 68 |
GSM1296087 | O_non-lesional_pre-dose | 264.11 | 58 |
GSM1296118 | P_non-lesional_pre-dose | 498.77 | 67 |
GSM1296114 | Q_non-lesional_pre-dose | 387.75 | 63 |
GSM1296097 | R_non-lesional_pre-dose | 300.69 | 59 |
GSM1296106 | S_non-lesional_pre-dose | 371.94 | 62 |
GSM1296102 | U_non-lesional_pre-dose | 530.48 | 68 |
GSM1296122 | V_non-lesional_pre-dose | 464.29 | 66 |
GSM1296089 | W_non-lesional_pre-dose | 458.85 | 66 |
GSM1296083 | X_non-lesional_pre-dose | 656.6 | 72 |
GSM1296116 | Y_non-lesional_pre-dose | 431.4 | 64 |
GSM1296085 | Z_non-lesional_pre-dose | 541.14 | 69 |